UBQLN2 Protein <div class="infobox infobox-protein">
| Property | Value |Protein Name | Ubiquilin-2 |Gene | UBQLN2 |UniProt ID | Q9R0R5 |PDB ID | 2KVR, 2L2B |Molecular Weight | ~66 kDa |Subcellular Localization | Cytoplasm, nucleus |Protein Family | Ubiquilin family |
</div>
Overview
flowchart TD
UBQLN2["UBQLN2"] -->|"interacts with"| Ubiquitin["Ubiquitin"]
UBQLN2["UBQLN2"] -->|"involved in"| Protein_Degradation["Protein Degradation"]
UBQLN2["UBQLN2"] -->|"interacts with"| n26S_Proteasome["26S Proteasome"]
UBQLN2["UBQLN2"] -->|"protects against"| Oxidative_Stress["Oxidative Stress"]
UBQLN2["UBQLN2"] -->|"involved in"| Phase_Separation["Phase Separation"]
UBQLN2["UBQLN2"] -->|"interacts with"| Parkin["Parkin"]
UBQLN2["UBQLN2"] -->|"interacts with"| PHB2["PHB2"]
UBQLN2["UBQLN2"] -->|"implicated in"| Amyotrophic_Lateral_Sclerosis["Amyotrophic Lateral Sclerosis"]
UBQLN2["UBQLN2"] -->|"implicated in"| FTLD["FTLD"]
UBQLN2["UBQLN2"] -->|"activates"| Neurodegeneration["Neurodegeneration"]
UBQLN2["UBQLN2"] -->|"activates"| PROTEIN_DEGRADATION["PROTEIN_DEGRADATION"]
UBQLN2["UBQLN2"] -->|"associated with"| ALS["ALS"]
UBQLN2["UBQLN2"] -->|"interacts with"| HSP70["HSP70"]
UBQLN2["UBQLN2"] -->|"interacts with"| UNC5B["UNC5B"]
style UBQLN2 fill:#4fc3f7,stroke:#333,color:#000
...
UBQLN2 Protein <div class="infobox infobox-protein">
| Property | Value |Protein Name | Ubiquilin-2 |Gene | UBQLN2 |UniProt ID | Q9R0R5 |PDB ID | 2KVR, 2L2B |Molecular Weight | ~66 kDa |Subcellular Localization | Cytoplasm, nucleus |Protein Family | Ubiquilin family |
</div>
Overview
Mermaid diagram (expand to render)
Ubiquilin-2 (UBQLN2) is a pivotal ubiquitin-like protein that serves as a critical mediator of protein quality control in both the [ubiquitin-proteasome system](/mechanisms/ubiquitin-proteasome-system) and [autophagy](/mechanisms/autophagy-mechanisms)[@deng2011]. Pathogenic mutations in UBQLN2 cause familial [amyotrophic lateral sclerosis](/diseases/amyotrophic-lateral-sclerosis) (ALS) and [frontotemporal dementia](/diseases/frontotemporal-dementia) (FTD), with prominent psychiatric features, highlighting its essential role in neuronal health.
Structure UBQLN2 possesses a modular architecture that enables its diverse functions[@wu2012]:
N-Terminal Ubiquitin-Like (UBL) Domain
Size : ~70 amino acidsFunction : Binds to the 19S regulatory particle of the proteasomeInteraction : Facilitates delivery of ubiquitinated substrates to the proteasomeCentral Sti1 Domain
Structure : Proline-rich region with STI1-like heat shock chaperone motifsFunction : Mediates protein-protein interactionsFlexibility : Provides flexibility for substrate recognitionC-Terminal Ubiquitin-Associated (UBA) Domain
Size : ~60 amino acidsFunction : Binds monoubiquitin and polyubiquitin chainsSpecificity : Prefers K48-linked polyubiquitin (proteasomal signal)PXX Stem-Loop Region
Location : Between STI1 and UBA domainsFunction : Contains disease-causing mutations (P497H, P506T)Pathogenesis : Mutations disrupt substrate binding and proteasome targetingNormal Physiological Function
Proteasomal Degradation UBQLN2 serves as a shuttle receptor for proteasomal degradation[@deng2011]:
Substrate recognition : Binds ubiquitinated proteins via the UBA domainProteasome targeting : Delivers substrates via UBL-proteasome interactionQuality control : Bridges misfolded proteins to degradation machineryAutophagy The protein also participates in autophagic degradation:
Aggrephagy : Selective [autophagy](/entities/autophagy) of protein aggregatesProteostasis coordination : Links proteasome and autophagy systemsCargo receptor function : Recognizes and delivers aggregate-prone proteins to autophagosomesProtein Quality Control UBQLN2 functions at multiple cellular quality control checkpoints:
Cytoplasmic quality control : Surveillance of misfolded cytosolic proteinsNuclear quality control : Handles ubiquitinated nuclear proteinsMembrane protein quality control : Participates in ER-associated degradation (ERAD)Role in ALS/FTD
Genetic Basis Dominant mutations in UBQLN2 cause familial ALS/FTD[@chang2015]:
P497H : First identified pathogenic mutation in X-linked ALS/FTD familiesP506T : Second major mutation with similar phenotypeX-linked inheritance : Mutations cause disease in hemizygous males and heterozygous femalesIncomplete penetrance : Some carriers remain asymptomaticPathophysiological Mechanisms
Proteostasis Disruption Mutant UBQLN2 impairs protein quality control[@chang2015]:
Impaired substrate delivery : Mutations reduce proteasome targetingAggregate accumulation : Ubiquitinated proteins accumulate in [neurons](/entities/neurons)Proteasome inhibition : Mutant UBQLN2 may directly inhibit proteasome activityStress Granule Dynamics UBQLN2 localizes to stress granules[@alexander2018]:
Stress granule formation : UBQLN2 partitions to stress granules under translational arrestImpaired dissolution : Mutant UBQLN2 delays stress granule clearanceSequestration of RNA : May contribute to RNA metabolism defectsNuclear-Cytoplasmic Transport Emerging evidence suggests UBQLN2 affects nucleocytoplasmic transport:
Nuclear pore association : Localizes to nuclear pore complexesImportin dysfunction : May affect nuclear import of proteins[TDP-43](/mechanisms/tdp-43-proteinopathy) interplay : Synergizes with TDP-43 pathology in ALSClinical Phenotype UBQLN2 mutations cause a distinctive clinical syndrome:
Motor neuron disease : ALS phenotype with combined upper/lower motor neuron signsCognitive/behavioral changes : FTD features including disinhibition and apathyPsychiatric manifestations : Prominent psychosis and mood changesRapid progression : Typically aggressive disease courseTherapeutic Implications
Therapeutic Strategies Several approaches are being explored to target UBQLN2 pathology:
Proteostasis enhancement : Compounds that boost proteasome activityAutophagy induction : Agents that enhance aggrephagyStress granule modulators : Drugs targeting stress granule dynamics[Riluzole](/therapeutics/riluzole) — Approved ALS treatment
[Edaravone](/therapeutics/edaravone) — Antioxidant ALS therapy
[Antisense oligonucleotides](/therapeutics/antisense-oligonucleotide-therapy) — Gene-specific approaches
Key Publications
[Deng, H.X. et al. (2011) UBQLN2 mutations in ALS and FTD (Nature)](https://doi.org/10.1038/nature10524)
[Wu, J.J. et al. (2012) UBQLN2 structure and function (Journal of Biological Chemistry)](https://doi.org/10.1074/jbc.M112.364067)
[Chang, L. & Monteiro, M.J. (2015) UBQLN2 mutations reveal proteostasis defects (Neuron)](https://doi.org/10.1016/j.neuron.2015.10.023)
[Alexander, E.J. et al. (2018) UBQLN2 in stress granule pathology (Acta Neuropathologica)](https://doi.org/10.1007/s00401-018-1863-6)
Cross-References
[UBQLN2 Gene](/genes/ubqln2) — Gene encoding UBQLN2
[Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis) — Primary disease
[Frontotemporal Dementia](/diseases/frontotemporal-dementia) — Associated dementia
[TDP-43](/proteins/tardbp-protein) — TARDBP protein in ALS
[FUS](/proteins/fus-protein) — FUS protein in ALS
[Ubiquitin-Proteasome System](/mechanisms/ubiquitin-proteasome-system) — [UPS](/mechanisms/ubiquitin-proteasome-system) pathway
[Autophagy Mechanisms](/mechanisms/autophagy-mechanisms) — Autophagy pathway
See Also
[Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)
[Frontotemporal Dementia](/diseases/frontotemporal-dementia)
[Protein Aggregation](/mechanisms/protein-aggregation-mechanisms)
External Links
[UniProt Q9R0R5](https://www.uniprot.org/uniprot/Q9R0R5)
[PDB 2KVR](https://www.rcsb.org/structure/2KVR)
[OMIM: 300364](https://www.omim.org/entry/300364)
[PubMed UBQLN2 ALS](https://pubmed.ncbi.nlm.nih.gov/?term=UBQLN2+ALS)
References
[Deng, H.X. et al, Mutations in UBQLN2 cause dominant X-linked ALS and FTD (2011)](https://doi.org/10.1038/nature10524)
[Wu, J.J. et al, Structural and functional analysis of UBQLN2 protein (2012)](https://doi.org/10.1074/jbc.M112.364067)
[Chang, L. & Monteiro, M.J, Defective proteostasis in UBQLN2-linked ALS/FTD (2015)](https://doi.org/10.1016/j.neuron.2015.10.023)
[Alexander, E.J. et al, UBQLN2 in stress granule pathology of ALS/FTD (2018)](https://doi.org/10.1007/s00401-018-1863-6)
Pathway Diagram The following diagram shows the key molecular relationships involving UBQLN2 Protein discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)
Show full description